Anacura - AnaBioTec is setting up an analytical therapeutic oligonucleotides platform
AnaBioTec is specialized in analytical method development and validation as well as stability and release studies of drug substances and products according to GMP guidelines.
AnaBioTec, focusing on Small molecules; Biologics & Biosimilars; and Cell & Gene Therapy solutions, is presently investing in knowledge and expertise to enable quality analytical services for therapeutic oligonucleotides. For this a state-of-the-art high resolution mass spectrometer will be operational at the end of 2020.
AnaBioTec is also investing in building up knowledge, which is reflected by a recent paper entitled: “Current State of Oligonucleotide Characterization Using Liquid Chromatography−Mass Spectrometry: Insight into Critical Issues”, co-authored by William D. van Dongen of Anabiotech, published in J. Am. Soc. Mass Spectrom. 2020, 31, 1775−1782, https://pubs.acs.org/doi/10.1021/jasms.0c00179.
